Parsatuzumab Biosimilar – Anti-EGFL7 mAb – Research Grade

Reference:
Product nameParsatuzumab Biosimilar - Anti-EGFL7 mAb - Research Grade
SourceCAS 1312797-14-0
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsParsatuzumab,RG7414,RO5490248,EGFL7,anti-EGFL7
ReferencePX-TA1300
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Parsatuzumab Biosimilar - Anti-EGFL7 mAb - Research Grade

General information on Anti-EGFL7[Homo sapiens] (Parsatuzumab) Monoclonal Antibody

Parsatuzumab is investigated for the treatment of Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Parsatuzumab Biosimilar – Anti-EGFL7 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Stable Isotope Labelled Parsatuzumab Biosimilar – Anti-EGFL7 mAb – Research Grade
SIL

Stable Isotope Labelled Parsatuzumab Biosimilar – Anti-EGFL7 mAb – Research Grade

PX-TA1300-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products